Novonesis (Novozymes) B (OTC:NVZMY) Stock, Earnings Estimates, EPS, And Revenue

Novonesis (Novozymes) B reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 27
EPS
$0.690
Quarterly Revenue
$2.1B
Annual Revenue
(as of Jun 30)
$3B

Analyze the earnings history of Novonesis (Novozymes) B using advanced sorting and filters.

Data brought to you by Benzinga APIs

Novonesis (Novozymes) B (NVZMY) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Dec 20232024-02-01$0.36$0.44-18.2 %
Sep 20232023-10-26$0.49$0.4216.7 %
Jun 20232023-08-09$0.32$0.42-23.8 %
Mar 20232023-04-26$0.41$0.44-6.82 %

Novonesis (Novozymes) B (NVZMY) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Dec 20232024-02-01$664.23M$674.70M-1.55 %
Sep 20232023-10-26$650.51M$634.28M2.56 %
Jun 20232023-08-09$616.52M$632.02M-2.45 %
Mar 20232023-04-26$666.31M$662.60M0.56 %

FAQ

Q

When is Novonesis (Novozymes) B (OTCPK:NVZMY) reporting earnings?

A

Novonesis (Novozymes) B (NVZMY) is scheduled to report earnings on February 15, 2025. The last reported earnings were for reported on August 27, 2024 for H1.

Q

What were the latest earnings per share (EPS) for Novonesis (Novozymes) B (OTCPK:NVZMY)?

A

The Actual EPS was $0.69, which beat the estimate of $0.00.

Q

What were Novonesis (Novozymes) B’s (OTCPK:NVZMY) revenues?

A

The Actual Revenue was $2.1B, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.